Cargando…
Fluorescent Advanced Glycation End Products and Their Soluble Receptor: The Birth of New Plasmatic Biomarkers for Risk Stratification of Acute Coronary Syndrome
OBJECTIVE: Advanced glycation end products (AGEs) have pathophysiological implications in cardiovascular diseases. The aim of our study was to evaluate the prognostic value of fluorescent AGEs and its soluble receptor (sRAGE) in the context of acute coronary syndrome (ACS), both in-hospital phase an...
Autores principales: | Raposeiras-Roubín, Sergio, Rodiño-Janeiro, Bruno K., Paradela-Dobarro, Beatriz, Grigorian-Shamagian, Lilian, García-Acuña, José M., Aguiar-Souto, Pablo, Jacquet-Hervet, Michel, Reino-Maceiras, María V., González-Juanatey, José R., Álvarez, Ezequiel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772878/ https://www.ncbi.nlm.nih.gov/pubmed/24058542 http://dx.doi.org/10.1371/journal.pone.0074302 |
Ejemplares similares
-
Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report
por: Raposeiras-Roubín, Sergio, et al.
Publicado: (2012) -
Current status of NADPH oxidase research in cardiovascular
pharmacology
por: Rodiño-Janeiro, Bruno K, et al.
Publicado: (2013) -
Alteration of platelet GPVI signaling in ST-elevation myocardial infarction patients demonstrated by a combination of proteomic, biochemical, and functional approaches
por: Vélez, Paula, et al.
Publicado: (2016) -
Evolution and bad prognostic value of advanced glycation end products after acute heart failure: relation with body composition
por: Paradela-Dobarro, Beatriz, et al.
Publicado: (2017) -
Advanced Glycation End Products Evolution after Pancreas-Kidney Transplantation: Plasmatic and Cutaneous Assessments
por: Martins, La Salete, et al.
Publicado: (2016)